Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients - Wikidata - wikimedia - TriplyDB

Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients

Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients

http://www.wikidata.org/entity/Q35807013

about

Galactomannan detection for invasive aspergillosis in immunocompromised patients Earlier diagnosis of invasive fusariosis with Aspergillus serum galactomannan testing Systematic review and meta-analysis of detecting galactomannan in bronchoalveolar lavage fluid for diagnosing invasive aspergillosis Establishment and application of real-time quantitative PCR for diagnosing invasive aspergillosis via the blood in hematological patients: targeting a specific sequence of Aspergillus 28S-ITS2.Importance of operational factors in the reproducibility of Aspergillus galactomannan enzyme immune assay Correlation between Circulating Fungal Biomarkers and Clinical Outcome in Invasive Aspergillosis.Serum galactomannan index for early prediction of mortality in immunocompromised children with invasive pulmonary aspergillosis.The Role of Biomarkers for Diagnosis of and Therapeutic Decisions Related to Invasive Aspergillosis in Children Does galactomannan testing increase diagnostic accuracy for IPA in the ICU? A prospective observational study.The serum galactomannan index predicts mortality in hematopoietic stem cell transplant recipients with invasive aspergillosis.Laboratory diagnosis of invasive aspergillosis: from diagnosis to prediction of outcome Challenges in microbiological diagnosis of invasive Aspergillus infections.Application of diagnostic markers to invasive aspergillosis in children.Utility of bronchoalveolar lavage fluid galactomannan alone or in combination with PCR for the diagnosis of invasive aspergillosis in adult hematology patients: a systematic review and meta-analysis.Enhancing molecular approaches for diagnosis of fungal infections.Non-cultural methods for the diagnosis of invasive fungal disease.The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.Characteristics of invasive aspergillosis in neutropenic haematology patients (Sousse, Tunisia).Diagnostic accuracy of the Aspergillus-specific bronchoalveolar lavage lateral-flow assay in haematological malignancy patients.Improving case finding of invasive aspergillosis in children using string searches.Circulating Aspergillus fumigatus DNA Is Quantitatively Correlated to Galactomannan in Serum.Fungal Pneumonia in Patients with Hematologic Malignancy and Hematopoietic Stem Cell Transplantation.Galactomannan and 1,3-β-d-Glucan Testing for the Diagnosis of Invasive Aspergillosis.Pediatric Invasive Aspergillosis.Galactomannan, a Surrogate Marker for Outcome in Invasive Aspergillosis: Finally Coming of Age.The State-of-the-Art Mycology Laboratory: Visions of the Future

P2860

Q24186895-3CF38BBD-4A45-432B-ACCC-782B23348DA5 Q31149815-EE70027F-6A5A-480E-A3B2-D1D7F227DC32 Q34385038-45B94427-A696-4590-BA5C-726442F9898F Q34750807-2B1FD38B-1D67-45B7-8EA1-34197A42E9D6 Q35364077-6CE7410C-E198-4917-8303-E6FFA2CB6DFD Q35672970-5792C357-AF26-4C99-BEAB-2EB737C4F3CD Q35689788-71124989-A875-4CD9-A093-5859237F43BA Q36630700-73873C9E-8609-4AE6-BDB0-D64A382E1F94 Q36886708-791F64B2-4D84-4620-9E74-A2A21970C9B6 Q37151497-E9BE1EDB-A3B9-478D-969B-68372DB68F42 Q37287794-36217FB4-C78C-4EB5-82DD-481C0170C2AC Q37659157-1518818B-2805-4C1F-921D-866B514D6ED8 Q38066612-3BE42449-983A-4AE4-A4BB-55CB9286F4C4 Q38116964-5A9CE4EF-5C12-47A2-A5B9-4B999630C109 Q38165198-F5E6F025-BC47-4ED5-A4C7-44629D7EFD08 Q38266817-2BA54A8E-C462-4489-B25B-FC428AF2570F Q38508539-032608DB-723D-45E5-9476-358E75729B5F Q39022120-0D3BE74E-911F-46F8-8552-8815F1541BBB Q39367509-DD01007C-A7BB-45AB-9811-5C0AAED424E7 Q40626648-079CC3C3-5A20-48C6-A4DA-D8EEDCECD73E Q47140701-1C3CEC83-C8C1-4ABE-98A3-BAEFBA4641D4 Q47698782-FE4AF770-77C6-44ED-A444-6D6E7277D779 Q49612984-06A92774-05ED-4769-947E-F9AA836867BA Q49612998-179EB377-FF55-444E-9015-145732D5E6FC Q55241833-15810838-55B5-4D8B-A4D6-9A9F26D0D77F Q59294372-7DCCBC6E-3F50-4C22-BE98-ADEA14D54EF0

P2860

Prospective evaluation of clinical and biological markers to predict the outcome of invasive pulmonary aspergillosis in hematological patients

http://www.wikidata.org/entity/Q35807013

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Prospective evaluation of clin ...... osis in hematological patients

@ast

Prospective evaluation of clin ...... osis in hematological patients

@en

type

label

Prospective evaluation of clin ...... osis in hematological patients

@ast

Prospective evaluation of clin ...... osis in hematological patients

@en

prefLabel

Prospective evaluation of clin ...... osis in hematological patients

@ast

Prospective evaluation of clin ...... osis in hematological patients

@en

P1433

Q35807013-7C94D711-2516-43A0-A58C-5439D53B630A

P1476

Q35807013-C57B761E-07C4-442A-9092-C285AB359C98

P2093

Q35807013-0045BA99-AE16-4184-8771-75B81E83CDBD

Q35807013-2BE4F11D-767B-4607-9242-56354A0C651C

Q35807013-364E3910-D634-4523-9A41-7F83E5BE6724

Q35807013-392F634B-A350-46FB-BEE4-A02CDD04C8BA

Q35807013-3C750407-1F1B-4F32-A7D4-EEBEFF67E1C8

Q35807013-3E119E20-5C91-41A5-90B2-510B2A0B1C6D

Q35807013-43A8DFAC-BF36-41AF-B0CC-210B9ED4FC89

Q35807013-451DA8D1-0018-4DB6-A07A-2B81EB831256

Q35807013-5CDC146D-E56A-48E9-A945-2DDC100DB943

Q35807013-61872B43-995E-4BCC-96A5-02FA168148A2

P2860

Q35807013-0684FAAA-44A2-4538-B3B5-5AE1DD89DA66

Q35807013-097CA779-443A-4155-BFD9-1CE8ECE2B542

Q35807013-0D55ED59-ABC7-48D8-9FF8-F2C0E0F62101

Q35807013-19F921EC-4796-4272-96B4-EB8E5E3D9F10

Q35807013-2167B1D6-30F8-4908-B1E0-D72E2BD3D7FE

Q35807013-3853FC52-2AD4-411D-A359-4E408AA5ECC8

Q35807013-4C7562F7-C40B-4B77-AC91-2AC2806C7184

Q35807013-4E4E9503-C108-4CD6-80FC-AD533B9B2246

Q35807013-5F4EB185-0F0C-43E9-A980-0C77E572A6F8

Q35807013-7DCA2669-E329-4DE0-9A06-F25F8A540D54

P304

Q35807013-BAB039D8-18B0-49E0-BC3A-19A5A13C6278

P31

Q35807013-92966FE3-E2BF-41F3-9155-76B0E7146BCA

P356

Q35807013-5049C2E8-28D9-48C0-AC10-0F4154EC590F

P407

Q35807013-5F16E77D-7A87-4020-9D2E-799A7CC33364

P433

Q35807013-D54EED18-FC99-4DF8-83A5-2316118BB2B3

P478

Q35807013-1EB39AA6-5DC1-4D22-AED6-C0121BC6D41C

P577

Q35807013-D678FA1E-DA67-47C7-AAEA-56ECB2B82EFF

P698

Q35807013-F0403EB5-F879-4DAA-89E2-03916B7F0CDB

P921

Q35807013-C993F3E3-12CF-493F-942C-3C1E0F982A3D

P932

Q35807013-01AFB17A-8DF7-4EC1-AD3B-F177E766A659

P356

P1433

Journal of Clinical Microbiology

P1476

Prospective evaluation of clin ...... osis in hematological patients

@en

P2093

Abdellatif Tazi

http://www.w3.org/2001/XMLSchema#string

Anne Bergeron

http://www.w3.org/2001/XMLSchema#string

Anne Vekhoff

http://www.w3.org/2001/XMLSchema#string

Annie Sulahian

http://www.w3.org/2001/XMLSchema#string

Benoit Brethon

http://www.w3.org/2001/XMLSchema#string

Claire Bouges-Michel

http://www.w3.org/2001/XMLSchema#string

Claire Lacroix

http://www.w3.org/2001/XMLSchema#string

Emmanuel Raffoux

http://www.w3.org/2001/XMLSchema#string

Francis Derouin

http://www.w3.org/2001/XMLSchema#string

Françoise Isnard

http://www.w3.org/2001/XMLSchema#string

P2860

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

Liposomal amphotericin B as initial therapy for invasive mold infection: a randomized trial comparing a high-loading dose regimen with standard dosing (AmBiLoad trial)

Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis

Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis.

Randomized, double-blind trial of fluconazole versus voriconazole for prevention of invasive fungal infection after allogeneic hematopoietic cell transplantation.

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

Newer combination antifungal therapies for invasive aspergillosis.

Development of a serum-based Taqman real-time PCR assay for diagnosis of invasive aspergillosis.

Laboratory diagnosis of invasive aspergillosis.

A new sensitive sandwich enzyme-linked immunosorbent assay to detect galactofuran in patients with invasive aspergillosis

P304

823-830

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JCM.00750-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

50

http://www.w3.org/2001/XMLSchema#string

P577

2011-12-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22170907

http://www.w3.org/2001/XMLSchema#string

P921

P932

3295141

http://www.w3.org/2001/XMLSchema#string